Recombinant Humanized Antibody (HuCC49DeltaCH2) is capable of binding to TAG-72, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-TAG-72 mAb and CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-TAG-72 mAb and CL of human light chain. Exists as a disulfide linked dimer of the HC and LC hetero-dimer under non-reducing condition.
Figure 1 Fluorescence microscopic images of LS174T cells.
The cells were fixed with 3.7% paraformaldehyde and incubated for 1 hour at room temperature with murine CC49-Cy7, murine CC49 followed by murine CC49-Cy7, HuCC49ΔCH2-Cy7, and murine CC49 followed by HuCC49ΔCH2-Cy7.
Zou, P., Xu, S., Povoski, S. P., Wang, A., Johnson, M. A., Martin Jr, E. W., ... & Sun, D. (2009). Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Molecular pharmaceutics, 6(2), 428-440.
Figure 2 The relative mean fluorescence intensity in the tumor and liver regions of interest (ROIs) as a function of time after injection of Cy7, excessive murine CC49 plus HuCC49ΔCH2-Cy7, or HuCC49ΔCH2-Cy7.
Zou, P., Xu, S., Povoski, S. P., Wang, A., Johnson, M. A., Martin Jr, E. W., ... & Sun, D. (2009). Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Molecular pharmaceutics, 6(2), 428-440.
Figure 3 The relative fluorescence intensity of each tissue was labeled near the corresponding tissue.
Representative images of dissected organs of athymic nude mice bearing LS174T xenograft tumor sacrificed 2 hours or 18 hours after intravenous injection of 1 nmol of Cy7, excessive murine CC49 followed by 0.73 nmol HuCC49ΔCH2-Cy7, 0.73 nmol HuCC49ΔCH2-Cy7, or 0.50 nmol non-specific human IgG-Cy7. The relative fluorescence intensity of each tissue was labeled near the corresponding tissue.
Zou, P., Xu, S., Povoski, S. P., Wang, A., Johnson, M. A., Martin Jr, E. W., ... & Sun, D. (2009). Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Molecular pharmaceutics, 6(2), 428-440.
Figure 4 Tissue-to-heart ratios for the mice sacrificed 2 hours after injection
Zou, P., Xu, S., Povoski, S. P., Wang, A., Johnson, M. A., Martin Jr, E. W., ... & Sun, D. (2009). Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Molecular pharmaceutics, 6(2), 428-440.
Figure 5 Tissue-to-heart ratios for the mice sacrificed 18 hours after injection
Zou, P., Xu, S., Povoski, S. P., Wang, A., Johnson, M. A., Martin Jr, E. W., ... & Sun, D. (2009). Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Molecular pharmaceutics, 6(2), 428-440.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-723 | Mouse Anti-TAG72 Recombinant Antibody (clone Anatumomab); Fab Fragment | FuncS, IF, Neut, ELISA, FC, IP, WB | Mouse Fab (IgG1, κ) |
TAB-H60 | Anti-Human TAG-72 Recombinant Antibody (Satumomab) | ELISA, FC, IP, FuncS, IF, Neut, ICC | IgG1 - kappa |
TAB-249 | Anti-Human TAG-72 Recombinant Antibody (Minretumomab) | WB, FuncS, IF, Neut, ELISA, FC, IP | IgG1 |
TAB-002 | Anti-Human TAG72 Recombinant Antibody (Satumomab Pendetide) | IP, IF, FuncS, FC, Neut, ELISA, WB | IgG1 |
PABX-025-S (P) | Recombinant Human Anti-TAG-72 Antibody scFv Fragment (B72.3) | WB, Neut, FuncS | scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
AGTO-L070E | anti-TAG72 immunotoxin CC49 (scFv)-PE | Cytotoxicity assay, Functional assay |
CAT | Product Name | Application | Type |
---|---|---|---|
PFBW-119 | Human Anti-TAG72 Recombinant Antibody (clone HuCC49DeltaCH2); Fab Fragment | WB, ELISA | Humanized Fab |
FAMAB-0119-CN-F(E) | Mouse Anti-TAG72 Recombinant Antibody (clone B72.3); Fab Fragment | WB, ELISA | Mouse Fab |
FAMAB-0120-CN-F(E) | Human Anti-TAG72 Recombinant Antibody (clone ccM4); Fab Fragment | WB, ELISA | Human Fab |
FAMAB-0121-CN-F(E) | Human Anti-TAG72 Recombinant Antibody (clone hmM4); Fab Fragment | WB, ELISA | Human Fab |
FAMAB-0122-CN-F(E) | Human Anti-TAG72 Recombinant Antibody (clone FV/M4); Fab Fragment | WB, ELISA | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0285CL | Human Anti-TAG72 Recombinant Antibody (TAB-0285CL) | DB, IHC, BI, SPR | Human IgG |
TAB-0286CL | Human Anti-TAG72 Recombinant Antibody (TAB-0286CL) | DB, IHC, BI, SPR | Human IgG |
TAB-0285CL-S(P) | Human Anti-TAG72 Recombinant Antibody; scFv Fragment (TAB-0285CL-S(P)) | DB, IHC, BI, SPR | Human scFv |
TAB-0286CL-S(P) | Human Anti-TAG72 Recombinant Antibody; scFv Fragment (TAB-0286CL-S(P)) | DB, IHC, BI, SPR | Human scFv |
TAB-0285CL-F(E) | Human Anti-TAG72 Recombinant Antibody; Fab Fragment (TAB-0285CL-F(E)) | DB, IHC, BI, SPR | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-505CT | Humanized Anti-TAG72 Recombinant Antibody (TAB-505CT) | WB, ELISA | Humanized antibody |
TAB-505CT-S(P) | Humanized Anti-TAG72 Recombinant Antibody; scFv Fragment (TAB-505CT-S(P)) | WB, ELISA | Humanized scFv |
TAB-505CT-F(E) | Humanized Anti-TAG72 Recombinant Antibody; Fab Fragment (TAB-505CT-F(E)) | WB, ELISA | Humanized Fab |
PABX-025 | Recombinant Human Anti-TAG-72 Antibody (B72.3) | WB, Neut, FuncS, ELISA, Cyt | IgG |
PABX-025-F (E) | Recombinant Human Anti-TAG-72 Antibody Fab Fragment (B72.3 ) | WB, Neut, FuncS | Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
Gly-016LC | Recombinant Anti-Human TAG-72 Antibody (Fc glycosylation) | ELISA | Chimeric antibody (mouse/human) |
CAT | Product Name | Application | Type |
---|---|---|---|
FAMAB-0278YC | Mouse Anti-TAG72 Recombinant Antibody (clone nCC49) | FuncS | Mouse IgG |
FAMAB-0279YC | Human Anti-TAG72 Recombinant Antibody (clone cCC49) | FuncS | Chimeric (mouse/human) IgG |
FAMAB-0280YC | Human Anti-TAG72 Recombinant Antibody (clone HuCC49) | FuncS | Humanized IgG |
FAMAB-0315CQ | Mouse Anti-TAG72 Recombinant Antibody (clone ACT19) | IHC | Mouse IgG1, κ |
HPAB-A1328-YJ | Human Anti-TAG-72 Recombinant Antibody (clone hum4) | ELISA, Inhib, and SPR | Human IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
FAMAB-0315CQ-S(P) | Mouse Anti-TAG72 Recombinant Antibody (clone ACT19); scFv Fragment | ELISA | Mouse scFv |
FAMAB-0317CQ-S(P) | Mouse Anti-TAG72 Recombinant Antibody (clone CC49); scFv Fragment | WB, IP, IF, IHC, FC | Mouse scFv |
FAMAB-0119-CN-S(P) | Mouse Anti-TAG72 Recombinant Antibody (clone B72.3); scFv Fragment | WB, ELISA | Mouse scFv |
FAMAB-0120-CN-S(P) | Human Anti-TAG72 Recombinant Antibody (clone ccM4); scFv Fragment | WB, ELISA | Human scFv |
FAMAB-0121-CN-S(P) | Human Anti-TAG72 Recombinant Antibody (clone hmM4); scFv Fragment | WB, ELISA | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-249 | Afuco™ Anti-TAG72 ADCC Recombinant Antibody (Minretumomab), ADCC Enhanced | FuncS, IF, Neut, ELISA, FC | ADCC enhanced antibody |
AFC-TAB-H60 | Afuco™ Anti-TAG72 ADCC Recombinant Antibody (Satumomab), ADCC Enhanced | ELISA, FC, IP, FuncS, IF, Neut | ADCC enhanced antibody |
There are currently no Customer reviews or questions for PABW-119. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.